Haemonetics Corp (HAE)
85.46
+0.54
(+0.64%)
USD |
NYSE |
Nov 21, 16:00
85.46
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Price to Book Value: 4.884 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.853 |
| November 19, 2024 | 4.848 |
| November 18, 2024 | 5.039 |
| November 15, 2024 | 5.099 |
| November 14, 2024 | 5.186 |
| November 13, 2024 | 5.245 |
| November 12, 2024 | 5.336 |
| November 11, 2024 | 5.223 |
| November 08, 2024 | 4.996 |
| November 07, 2024 | 4.945 |
| November 06, 2024 | 4.467 |
| November 05, 2024 | 4.285 |
| November 04, 2024 | 4.215 |
| November 01, 2024 | 4.098 |
| October 31, 2024 | 4.079 |
| October 30, 2024 | 4.129 |
| October 29, 2024 | 4.190 |
| October 28, 2024 | 4.341 |
| October 25, 2024 | 4.332 |
| October 24, 2024 | 4.346 |
| October 23, 2024 | 4.201 |
| October 22, 2024 | 4.269 |
| October 21, 2024 | 4.292 |
| October 18, 2024 | 4.365 |
| October 17, 2024 | 4.353 |
| Date | Value |
|---|---|
| October 16, 2024 | 4.332 |
| October 15, 2024 | 4.310 |
| October 14, 2024 | 4.316 |
| October 11, 2024 | 4.298 |
| October 10, 2024 | 4.268 |
| October 09, 2024 | 4.363 |
| October 08, 2024 | 4.396 |
| October 07, 2024 | 4.425 |
| October 04, 2024 | 4.465 |
| October 03, 2024 | 4.476 |
| October 02, 2024 | 4.546 |
| October 01, 2024 | 4.529 |
| September 30, 2024 | 4.608 |
| September 27, 2024 | 4.511 |
| September 26, 2024 | 4.327 |
| September 25, 2024 | 4.244 |
| September 24, 2024 | 4.267 |
| September 23, 2024 | 4.318 |
| September 20, 2024 | 4.230 |
| September 19, 2024 | 4.244 |
| September 18, 2024 | 4.274 |
| September 17, 2024 | 4.327 |
| September 16, 2024 | 4.337 |
| September 13, 2024 | 4.301 |
| September 12, 2024 | 4.141 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.061
Minimum
Jan 27 2022
10.68
Maximum
Nov 27 2019
5.780
Average
5.078
Median
Apr 06 2023
Price to Book Value Benchmarks
| Boston Scientific Corp | 6.512 |
| Baxter International Inc | 2.139 |
| Globus Medical Inc | 2.840 |
| ResMed Inc | 6.884 |
| Integra Lifesciences Holdings Corp | 1.166 |
Price to Book Value Related Metrics
| PE Ratio | 35.46 |
| PS Ratio | 3.228 |
| Price to Free Cash Flow | 215.90 |
| Price | 85.46 |
| Earnings Yield | 2.82% |
| Market Cap | 4.292B |
| Operating PE Ratio | 26.57 |
| Normalized PE Ratio | 35.97 |